Oxygen Biotherapeutics Announces Second Quarter FY2013 Financial Results
Conference Call and Webcast
MORRISVILLE, N.C. -- December 06, 2012
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) today announced that the Company
plans to report second quarter fiscal year 2013 financial results on Form 10-Q
on Friday, December 14, 2012. Oxygen’s President and Chief Financial Officer
Michael Jebsen will host a conference call and live webcast to discuss the
results on Monday, December 17, 2012, at 11 a.m. EST.
To access the live teleconference, dial (800) 299-9630 (U.S. and Canada) or
(617) 786-2904 (international.) The participant passcode is 40837151. A live
webcast will be available on our web site
A replay of the webcast will be available on the Oxygen website, or by phone
for a limited time. To access the replay by phone, call (888) 286-8010 (U.S.
and Canada) or (617) 801-6888 (international). The passcode for the replay is
About Oxygen Biotherapeutics, Inc.
Oxygen Biotherapeutics, Inc. is developing medical and cosmetic products that
efficiently deliver oxygen to tissues in the body. The company has developed a
proprietary perfluorocarbon (PFC) therapeutic oxygen carrier called Oxycyte^®
that is currently in clinical and preclinical studies for intravenous delivery
for indications such as traumatic brain injury, decompression sickness and
stroke. The company is also developing PFC-based creams and gels for topical
delivery to the skin for dermatologic conditions and potentially wound care.
In addition, the Company has commercialized its Dermacyte^® line of skin care
cosmetics for the anti-aging market.
Oxygen Biotherapeutics, Inc.
Senior Vice President
Corporate Communications & Investor Relations
Press spacebar to pause and continue. Press esc to stop.